The use of patient-reported outcome measures to guide referral for hip and knee arthroplasty.
Price AJ. et al, (2020), Bone Joint J, 102-B, 941 - 949
The use of patient-reported outcome measures to guide referral for hip and knee arthroplasty.
Dakin H. et al, (2020), Bone Joint J, 102-B, 950 - 958
Economic evaluation of factorial trials: cost-utility analysis of the AFORRD 2x2x2 factorial trial of atorvastatin, omega-3 fish oil and action-planning
DAKIN H. et al, (2020), Value in Health
Which interactions matter in economic evaluations? A systematic review and simulation study
DAKIN H. and GRAY A., (2020), BMC Medical Research Methodology
Which interactions matter in economic evaluations? A systematic review and simulation study
Dakin HA. and Gray A., (2020)
Which interactions matter in economic evaluations? A systematic review and simulation study
Dakin H. and Gray A., (2020)
Accurately reflecting uncertainty when using patient-level simulation models to extrapolate clinical trial data
DAKIN H. et al, (2020), Medical Decision Making
The use of patient-reported outcome measures to guide referral for hip and knee replacement: Part 2 – a cost-effectiveness analysis
DAKIN H. et al, (2020), Bone and Joint Journal
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Reed SD. et al, (2020), Diabetes Care, dc190950 - dc190950
Cooled radiofrequency ablation of the genicular nerves for chronic pain due to osteoarthritis of the knee: a cost-effectiveness analysis based on trial data.
Desai M. et al, (2019), BMC Musculoskelet Disord, 20
The Arthroplasty Candidacy Help Engine tool to select candidates for hip and knee replacement surgery: development and economic modelling.
Price A. et al, (2019), Health technology assessment (Winchester, England), 23, 1 - 216
Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? An early cost-utility analysis.
ABEL L. et al, (2019), International Journal of Technology Assessment in Health Care
Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL
Reed SD. et al, (2018), DIABETOLOGIA, 61, S426 - S426
Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
Becker F. et al, (2018), DIABETOLOGIA, 61, S366 - S366